Drugs / monovalent oral polio vaccine
Trials 1 · a red edge is where a trial was stopped
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| — | NCT04504539 | Aug 2020 → May 2021 | — | Aga Khan University | Unknown | No outcome recorded |
Evidence & citations 4 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | monovalent oral polio vaccine | “mOPV (monovalent oral polio vaccine) is an oral polio vaccines which consists of only attenuated virus of serotypes 1” NCT04504539 ↗ |
| Known as | mOPV | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04504539 ↗ |
| Modality | Vaccine | “mOPV (monovalent oral polio vaccine) is an oral polio vaccines which consists of only attenuated virus of serotypes 1” NCT04504539 ↗ |
| Route | Oral | “mOPV (monovalent oral polio vaccine) is an oral polio vaccines” NCT04504539 ↗ |